Skip to content

Ivestigating the effect of rTMS on adult ADHD

Investigating the effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on treatments of symptoms attention deficit-hyperactivity disorder( ADHD) in adults aged 18-40

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240123060776N1
Enrollment
15
Registered
2024-05-30
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult attention deficit-hyperactivity disorder (adult ADHD). Attention-deficit hyperactivity disorders

Interventions

Intervention group: rTMS intervention will be in the form of 120% motor threshold on the right frontal cortex, or 18 Hz stimulation frequency, including 40 trains, for 2 seconds, with an interval of 2

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: age between 18 to 40 Ability to understand Persian language Diagnosis of attention deficit hyperactivity disorder (ADHD) based on DSM5 diagnostic criteria Informed consent of the individual

Exclusion criteria

Exclusion criteria: suffering from other psychiatric disorders except simple phobia and nicotine addiction, (psychiatric disorders including mood disorders (major depression or bipolar disorder), obsessive compulsive disorder, personality disorder (including antisocial), substance abuse) and psychosis risk of serious suicide taking antipsychotic, antidepressant or mood stabilizer drugs A history of epilepsy in yourself or a first-degree relative severe physical problems or neurological disorder Taking drugs that lower the seizure threshold The presence of a magnetic device or metal splinter in the head, and a cardiac pacemaker pregnancy

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical symptoms of hyperactivity, Connors questionnaire score, Brown questionnaire score ;Clinical global impression. Timepoint: before the start of the study (week=0)and three weeks after (week=3)and seven weeks after(week=7) the start of the intervention. Method of measurement: Connors questionnaire score, Brown questionnaire score ;Clinical global impression.;Attention deficit. Timepoint: before the start of the study (week=0)and three weeks after (week=3)and seven weeks after(week=7) the start of the intervention. Method of measurement: Connors questionnaire score, Brown questionnaire score ;Clinical global impression.;Accuracy and error in auditory and visual attention. Timepoint: before the start of the study (week=0)and three weeks after (week=3)and seven weeks after(week=7) the start of the intervention. Method of measurement: Integrated visual and auditory assessment (IVA-2) which is a Computer test.

Secondary

MeasureTime frame
Symptoms related to defects in executive functions. Timepoint: before the start of the study (week=0)and three weeks after (week=3)and seven weeks after(week=7) the start of the intervention. Method of measurement: Barkley Deficits in Executive Functioning Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Alaghband-rad

Tehran University of Medical Sciences

jalaghbandrad@gmail.com009855419151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026